Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo
- 22 February 2008
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 79 (1) , 49-61
- https://doi.org/10.1016/j.antiviral.2008.01.154
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cytomegalovirus UL97 Kinase Mutations That Confer Maribavir ResistanceThe Journal of Infectious Diseases, 2007
- Epidermal Growth Factor Receptor Is Not Required for Human Cytomegalovirus Entry or SignalingJournal of Virology, 2007
- Analysis of the Structure−Activity Relationship of Four Herpesviral UL97 Subfamily Protein Kinases Reveals Partial but not Full Functional Conservation†Journal of Medicinal Chemistry, 2006
- Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirusJournal of General Virology, 2005
- Identification of Inhibitors for a Virally Encoded Protein Kinase by 2 Different Screening Systems: In Vitro Kinase Assay and In-Cell Activity AssaySLAS Discovery, 2005
- The Human Cytomegalovirus UL44 Protein Is a Substrate for the UL97 Protein KinaseJournal of Virology, 2003
- Dendritic Cells under Influence of Mouse Cytomegalovirus Have a Physiologic Dual Role: to Initiate and to Restrict T Cell ActivationThe Journal of Infectious Diseases, 2003
- Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of ActionAntimicrobial Agents and Chemotherapy, 2002
- Preclinical and Toxicology Studies of 1263W94, a Potent and Selective Inhibitor of Human Cytomegalovirus ReplicationAntimicrobial Agents and Chemotherapy, 2002
- Exploitation of cellular signaling and regulatory pathways by human cytomegalovirusTrends in Microbiology, 2000